What is gensight biologics sa? Gensight Biologics SA is a France-based biopharmaceutical company. The Company develops and commercializes gene therapy-based treatments of retinal degenerative diseases. It develops approaches to prevent retinal degeneration in selected pathological conditions and to restore vision in patients suffering from low vision or blindness.What is gensight biologics lead product candidate gs010? GenSight Biologics’ lead product candidate, GS010, is in Phase III trials in Leber Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible blindness in teens and young adults.Is gensight proven? Proven. GenSight is fully ISO 9001 and ISO 27001 certified. We have a 25 year track record of success. Building the platform, delivering award winning solutions, supporting our clients. GenSight is trusted by many of the world’s biggest and best innovators.Why gengensight consultants? GenSight consultants are highly experienced professionals that have successfully delivered solutions to a wide range of leading companies. They will guide you towards best-practice, according to what is right for your particular business, now and in future. Often this means a phased approach, starting with your most urgent priorities.
Our products & pipeline. Our research has initially focused on gene therapy solutions for severe inherited retinal diseases. In the longer term, we hope to find solutions for patients faced with neurodegenerative diseases more generally.